Immuneering Corporation Public Float
Immuneering Corporation (IMRX) had Public Float of $101.10 million as of 2025-06-30, per its 10-K filed 2026-03-06.
Financial Statements › Notes
dei:EntityPublicFloat · last filed 2026-03-06
- 2025-06-30: Entity Public Float $101.10M.
- 2024-06-28: Entity Public Float $38.00M.
- 2023-06-30: Entity Public Float $239.00M.
- 2022-06-30: Entity Public Float $112.10M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $101.10M 10-K · filed 2026-03-06 |
| 2024-06-28 | $38.00M 10-K · filed 2025-03-20 |
| 2023-06-30 | $239.00M 10-K · filed 2024-03-01 |
| 2022-06-30 | $112.10M 10-K · filed 2023-03-06 |
| 2022-03-03 | $136.90M 10-K · filed 2022-03-10 |
| 2021-06-30 | $0.00 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |